Proteomic and Genomic Integration Identifies Kinase and Differentiation Determinants of Kinase Inhibitor Sensitivity in Leukemia Cells

Leukemia - United Kingdom
doi 10.1038/s41375-018-0032-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Quantitative Proteomic Analysis of Cofilin Phosphorylation in Myeloid Cells and Its Modulation Using the LIM Kinase Inhibitor Pyr1

PLoS ONE
Multidisciplinary
2018English

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Oncology and Therapy
Oncology
2019English

Bruton's Tyrosine Kinase Inhibitor Restrains WNT Signaling in Chronic Lymphocytic Leukemia

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Frequent Loss of RAF Kinase Inhibitor Protein Expression in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells

Cancer Research
Cancer ResearchOncology
2016English

KDM2B Regulates Choline Kinase Expression and Neuronal Differentiation of Neuroblastoma Cells

PLoS ONE
Multidisciplinary
2019English

Potentiation of the Lethality of the Histone Deacetylase Inhibitor LAQ824 by the Cyclin-Dependent Kinase Inhibitor Roscovitine in Human Leukemia Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2005English

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy